| Use of a genetically engineered E. coli overexpressing β-glucuronidase accompanied by glycyrrhizic acid, a natural and anti-inflammatory agent, for directed treatment of colon … A Afkhami-Poostchi, M Mashreghi, M Iranshahi, MM Matin International Journal of Pharmaceutics 579, 119159, 2020 | 27 | 2020 |
| Coadministration of auraptene and radiotherapy; a novel modality against colon carcinoma cells in vitro and in vivo H Salari, A Afkhami-Poostchi, S Soleymanifard, S Nakhaei-Rad, ... International Journal of Radiation Biology 96 (8), 1051-1059, 2020 | 10 | 2020 |
| Synthesis of tertiary amine functionalized Multi-Stimuli-Responsive latex nanoparticles by semicontinuous emulsion Polymerization: Investigation of responsivities and … ZS Hosseini, A Abdollahi, A Dashti, MM Matin, A Afkhami-Poostchi Journal of Molecular Liquids 352, 118697, 2022 | 6 | 2022 |
| Use of bacterial ghosts as novel drug delivery systems to improve cancer treatment A Afkhami Poostchi, M Moghaddam Matin 1st International Nastaran Cancer Symposium-2015, 2015 | 2 | 2015 |
| Use of bacterial ghosts as novel drug delivery systems to improve cancer treatment A Afkhami-Poustchi, MM Matin Advanced drug delivery reviews 57 (9), 1381-91, 2005 | 1 | 2005 |
| Prodrug converting enzyme gene delivery by E. coli for colon cancer therapy A Afkhami Poostchi, M Iranshahi, M Mashreghi, M Moghaddam Matin 2nd International Stem Cells & Regenerative Medicine Congress, 2017 | | 2017 |
| Use Of Myeloid-Derived Suppressor Cells As A Targeted And Promising Delivery System For Tumor Immunotherapy A Afkhami Poostchi, M Moghaddam Matin دومین سمپوزیوم بین المللی سرطان نسترن ۱۳۹۵, 2016 | | 2016 |
| Bacteria-Directed Enzyme Prodrug Therapy, A Novel And Reliable Prospective Method For Targeted Cancer Therapy A Afkhami Poostchi, M Moghaddam Matin دومین سمپوزیوم بین المللی سرطان نسترن ۱۳۹۵, 2016 | | 2016 |
